BioWorld-International-2006-07-19
Actelion, Roche Sign $630M Autoimmunity Product Deal
Actelion, Roche Sign $630M Autoimmunity Product Deal
Shrugging off recent disappointments in the clinic, Actelion AG signed what is likely to be one of the landmark licensing deals in European biotechnology in 2006. (BioWorld International)

